Introduction {#sec1_1}
============

It has been shown that mechanical thrombectomy (MT) associated with intravenous thrombolysis (IVT) treatment is effective during the acute phase of cerebral infarction with proximal occlusion of the anterior circulation in reducing disability at 3 months \[[@B1], [@B2], [@B3], [@B4], [@B5], [@B6]\]. Treatment by MT alone versus standard-of-care treatment has only been assessed retrospectively in subgroups of randomized controlled trials, with a significant difference in favor of the treatment. These results have led to a discussion about the benefits of MT without IVT in cases of proximal occlusion \[[@B7]\]or distal ICA occlusion \[[@B8]\]. A recent study and meta-analysis suggested a better prognosis for patients who receive a combined procedure \[[@B9], [@B10]\]; however another meta-analysis found no association between a combined procedure and improved outcomes \[[@B11]\]. The impact of IVT on MT is widely debated, in particular because the perfusion time could delay MT. On the other hand, IVT could be associated with faster recanalization following the thrombectomy procedure \[[@B12]\], but this hypothesis was not confirmed when studied in a larger cohort \[[@B13]\]. Following the assumption that IVT patients are recanalized faster than those receiving MT only, we hypothesized that other factors, including location of the thrombus and stroke etiology, could influence revascularization time.

Materials and Methods {#sec1_2}
=====================

Among patients prospectively included in the Besançon stroke registry (RUN-FC, previously described) \[[@B14], [@B15]\] from January 1, 2015, to December 31, 2016, we conducted a retrospective study including all patients with acute ischemic stroke (AIS) who were referred for an MT procedure. The local legal agreements were obtained (CNIL agreement 1042748). The study population included 123 stroke patients. Seventeen of those patients were excluded from this study because the MT was not performed due to angiographic technical difficulties (puncture failure or failure to catheterize the common or internal carotid artery \[ICA\]). Nine patients, all of whom underwent IVT, appeared recanalyzed at the diagnostic angiography step before MT and were also excluded. One hundred six patients were included in our study. The data concerning the duration of the IVT and MT procedures was collected prospectively by the on-duty neurology team. The clinical data was analyzed by the neurology team. The imaging data was collected by a neurologist qualified in neurovascular pathology and reviewed by an interventional neuroradiologist and a neurologist qualified in neurovascular pathology. Medical records were used to determine stroke etiology, which was categorized according to the TOAST \[[@B16]\] classification by 2 neurologists. The classification procedure was standardized in staff meetings for the neurovascular department or multidisciplinary meetings.

Parameters Related to the Revascularization Procedure {#sec2_1}
-----------------------------------------------------

The variables studied were: (1) the duration of the procedure, defined as the time from groin puncture to the first image from the first cerebral angiographic test acquired after revascularization, which is used to calculate the revascularization time; (2) the time from angiographic clot visualization to revascularization, reflecting the duration of catheterization and avoiding problems concerning femoral puncture or catheterization of the vessels from the aortic arch; (3) the modified Thrombolysis in Cerebral Ischemia (mTICI) scale score \[[@B17]\] (0, no flow beyond the occlusion; 1, minimal reperfusion; 2a, less than 50% of the affected vascular territory reperfused; 2b, greater than 50% reperfusion; and 3, complete reperfusion), which was considered successful at 2b or 3; and (4) prognosis at 3 months as defined by the modified Rankin scale \[[@B18]\] (functional independence corresponding to a score of 0--2), which was collected by a physician from the RUN-FC stroke network.

Successful Revascularization Subgroup {#sec2_2}
-------------------------------------

To determine the effect of IVT on the MT procedure, we analyzed a subgroup of patients who were considered to have successful revascularization (mTICI 2b or 3). The other cases (TICI \<2b) were not considered, because the interventional neuroradiologist stopped the procedure as a result either of technical difficulties or a long time between symptom onset and the procedure. Within this subgroup, we compared revascularization times for the combined procedure group versus the MT-only group.

Statistical Analysis {#sec2_3}
--------------------

A Mann-Whitney-Wilcoxon test was completed for mean comparisons. Qualitative variables were compared using a Fischer test. *p* \< 0.05 was considered statistically significant. Analyses were performed using R software.

Results {#sec1_3}
=======

Out of 106 patients, 83 patients underwent the combined procedure and 23 patients underwent the MT procedure only. The time of artery puncture was not indicated in 9 cases. The NIHSS score was not reported in 2 patients. The mRS score at 3 months was not recorded for 1 patient who moved to another country. The patients\' characteristics are summarized in Table [1](#T1){ref-type="table"}.

The patients treated with combined IVT and MT procedures were younger than the patients who underwent MT only (mean age: 67 vs. 74 years) and the time from the onset of symptoms to clot visualization was longer (mean time: 308 vs. 300 min). Patients treated solely by MT were more often under anticoagulant therapy (52 vs. 8%; *p* \< 0.001) or under both anticoagulant and antiplatelet therapy (22 vs. 2%; *p* = 0.0051) on admission, and the stroke etiology was more often of cardioembolic origin (91 vs. 51%; *p* \< 0.001). There was no significant difference regarding sex, NIHSS score, or antiplatelet therapy. In the MT-only group, the causes of contraindication to IVT were a period of time exceeding 4.5 h in 52% of the cases, patients under anticoagulant treatment in 39% of the cases, and other hemorrhagic risk in 17% of the cases. Regarding the etiology for the whole cohort, 63 strokes were cardioembolic in origin (mean age: 73 years) and 43 strokes were noncardioembolic (mean age: 62 years).

Analysis of the Full Cohort {#sec2_4}
---------------------------

In the full cohort, there was no significant difference in revascularization time for patients who received MT-only treatment and patients who underwent a combined procedure (Table [1](#T1){ref-type="table"}; 73 vs. 69 min, respectively; *p* = 0.36). Among the full cohort of patients who received MT-only treatment, those who were receiving treatment with anticoagulants at admission had a revascularization time comparable to that of those who were not receiving this treatment (80.5 vs. 63.5 min, *p* = 0.197). In the full cohort, patients with tandem occlusion had a revascularization time similar to that of those who did not present with tandem occlusion, and patients with or without cardioembolic infarct presented with similar revascularization times (Table [2](#T2){ref-type="table"}).

Analysis of the Successful Revascularization Subgroup {#sec2_5}
-----------------------------------------------------

In the successful revascularization (mTICI 2b-3) subgroup, we found no significant difference regarding the revascularization time in patients who received MT-only treatment and patients who underwent a combined procedure (Table [3](#T3){ref-type="table"}). Patients in the MT-only group were more likely to be scored mTICI 3 although the difference was not statistically significant (47 vs. 21% in the combined procedure group; *p* = 0.056).

Patients with tandem occlusion in this subgroup were revascularized less quickly, with an average revascularization time of 76 versus 61 min among those without carotid occlusion, but the difference was not significant (*p* = 0.075; Table [4](#T4){ref-type="table"}). In this cohort only 1 patient required balloon angioplasty on the extracranial ICA, and no ICA stenting was performed.

There was no significant difference within the successful revascularization subgroup in terms of the puncture-revascularization time between patients with a cardioembolic etiology compared to the others (Table [4](#T4){ref-type="table"}). However, the time between clot visualization and revascularization was significantly shorter in the cardioembolic group (41 vs. 56 min; *p* = 0.024).

Among patients with successful revascularization after MT-only treatment, those who were under anticoagulant therapy had a revascularization time comparable to that of those who were not receiving anticoagulant therapy (59.7 vs. 68.9 min; *p* = 0.93).

Discussion {#sec1_4}
==========

In our experience, the time taken for the MT procedure for AIS was not shorter in patients treated with combined IVT and MT procedures versus patients treated with MT only. These results do not support the first data published on the subject \[[@B12]\], but they are similar to those of a more recent study \[[@B13]\]. However, in our series the 2 groups were not homogeneous; patients in the MT-only group were older. It is possible that these patients had more advanced atheromatous lesions, which would have presented a less favorable prognosis and made the procedure more difficult. Ongoing randomized controlled trials (MR CLEAN NO IV and SWIFT DIRECT) are necessary to confirm the influence of IVT on MT. A higher number of MT-only patients presented with cardioembolic infarction and so the procedure could have been affected by histology-specific thrombi. In addition, this group also contained more patients under anticoagulation therapy, which is likely to be secondary to more prevalent cardioembolic pathologies. Anticoagulation could have an impact on thrombus dissolution during the procedure.

Demographic data from our cohort was similar to that of HERMES patients \[[@B19]\] regarding the mean age (68 years), the percentage of women (48% in the intervention group and 46% in the control group), and the baseline NIHSS score (median: 17). On the other hand, in our series 59% of the patients were diagnosed with a cardioembolic stroke at discharge, with 51% in the IVT+MT group and 91% in the MT-only group. In a recent meta-analysis \[[@B11]\], a cardioembolic etiology was reported in 46.7% of the cases in the IVT+MT group and in 56.6% of the cases in the MT-only group. These results seem to be similar regarding the combined therapy; however, in our MT-only group the percentage of patients with a cardioembolic etiology was higher (91 vs. 56.6%). This may not be significant and could be related to the fact that our MT-only group is small (23 patients) and has a higher average age than the meta-analysis (74 vs. 67 years).

We analyzed the subgroup of patients with successful revascularization in order to avoid including potential reduced revascularization times linked to the decision to stop or continue a procedure. This situation was quite frequent in 2015--2016, because most neurointerventionists respected the 6-h window advised by the first positive randomized controlled trials \[[@B1], [@B3], [@B5]\]. In the subgroup of patients with favorable revascularization scores (mTICI 2b-3), a nonsignificantly higher number of patients undergoing MT-only treatment achieved mTICI 3. This suggests that IVT therapy may have a negative influence on revascularization. We could hypothesize that partial fragmentation of the thrombus due to IVT leads to distal emboli that affect the final mTICI score. In our subgroup of mTICI 2b-3 patients, the shorter time from clot visualization to revascularization in patients presenting with cardioembolic infarction seems to contradict the data in the literature from another cohort \[[@B20]\]. This could be explained by the fact that in the published series the patients were younger (mean age: 58 and 59 years in the cardioembolic and noncardioembolic groups, respectively) compared to our cohort. This could be due to the fact that those patients were recruited from 2011 to 2014, before the first positive thrombectomy randomized controlled trials were published. In our cohort with older patients, the frequent atherosclerotic lesions potentially associated with a noncardioembolic etiology could play a predominant role. We can therefore hypothesize that age could have more of an impact on recanalization time than stroke etiology.

The revascularization time of patients presenting with tandem occlusion suggests that these patients remain good candidates for endovascular therapy. Our cohort displayed an additional mean delay of an average of 6 min for puncture-revascularization time among these patients, with no significant difference between these patients and patients not presenting with carotid occlusion. There was no difference in the mRS scores. This data is consistent with previous studies \[[@B21], [@B22]\]. However, in the mTICI 2b-3 subgroup, the revascularization time showed a tendency to be longer for patients presenting with tandem occlusion by an additional 15 min. The fact that this is not highlighted in the full cohort leads us to believe that there is a large bias toward the MT procedure being stopped prematurely for patients with an mTICI score lower than 2b. Moreover, patients presenting with tandem occlusion have prolonged times between clot visualization and revascularization. This could be explained by specific problems concerning revascularization other than carotid recanalization. One explanation could be the higher prevalence of distal ICA occlusion in the tandem group (79 vs. 11%, *p* \< 0.001).

Our study has some limitations. We present a relatively small series, and so we cannot rule out a detectable statistical link for an increased number of patients. However, the statistical difference in terms of procedure time that was found previously was with a smaller series \[[@B12]\]. The retrospective analysis cannot rule out causal links between the factors studied and patient outcomes.

Conclusion {#sec1_5}
==========

Among our retrospective cohort of patients revascularized by MT, there was no difference in reperfusion time between those who received IVT+MT treatment and those who underwent MT-only treatment. Patients presenting with tandem occlusion tended to have their procedure extended by a mean time of 15 min, but with no difference in terms of clinical prognosis. More studies about the procedure time of MT for stroke analyzing patients with successful revascularization are needed.
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###### 

Patient characteristics and comparison between the IVT+MT and MT groups

  Characteristic                                        Total (*n* = 106)   IVT+MT (*n* = 83)   MT (*n* = 23)   *p*
  ----------------------------------------------------- ------------------- ------------------- --------------- ---------
  Females                                               54 (51)             39 (47)             15 (65)         0.16
  Age, years                                            69                  67                  74              0.029
  Median NIHSS score at admission                       18                  18                  19              0.62
  mTICI 2b-3                                            72 (68)             57 (69)             15 (65)         0.8
  Anticoagulant therapy at admission                    19 (18)             7 (8)               12 (52)         \<0.001
  Antiplatelet therapy at admission                     29 (27)             21 (25)             8 (35)          0.43
  Anticoagulant and antiplatelet therapy at admission   7 (7)               2 (2)               5 (22)          0.0051
  Location                                                                                                      
   Right                                                40 (38)             32 (39)             8 (35)          0.85
   Tandem                                               19 (18)             17 (20)             2 (9)           0.25
   Dissection                                           2 (2)               2 (2)               0 (0)           1
   Distal ICA occlusion                                 25 (24)             21 (25)             4 (17)          0.58
   M1                                                   66 (62)             53 (64)             13 (57)         0.63
   M2                                                   7 (7)               4 (5)               3 (13)          0.17
   Posterior circulation                                8 (8)               5 (6)               3 (13)          0.37
  Revascularization attempts                                                                                    
   Attempts, *n*                                        2.5                 2.4                 2.7             0.31
   Stent retriever                                      48 (45)             36 (43)             12 (52)         0.49
  Duration                                                                                                      
   From onset of symptoms to puncture                   292                 290                 298             0.23
   From onset of symptoms to clot visualization         307                 308                 300             0.045
   From puncture to revascularization                   70                  69                  73              0.36
   From clot visualization to revascularization         53                  52                  56              0.24
  General anesthesia                                                                                            
   Before the procedure                                 42 (40)             31 (37)             11 (48)         0.47
   During the procedure                                 8 (8)               5 (6)               3 (13)          0.37
  Rankin score mRS 0--2                                 27 (26)             23 (28)             4 (17)          0.42

Values are presented as means or numbers (%) unless otherwise stated.

###### 

Association of tandem occlusion and cardioembolic etiology with revascularization in the whole cohort

  Full cohort                                                   Tandem    Non-tandem   *p*    Cardioembolic   Non-cardioembolic   *p*
  ------------------------------------------------------------- --------- ------------ ------ --------------- ------------------- -------
  Patients, *N*                                                 19        87                  63              43                  
  Mean time from puncture to revascularization, min             74        68           0.20   63              78                  0.076
  Mean time from clot visualization to revascularization, min   58        52           0.20   47              61                  0.12
  mTICI 2b-3, *n* (%)                                           11 (58)   61 (70)      0.59   45 (71)         27 (63)             0.4
  mRS 0--2, *n* (%)                                             5 (26)    22 (25)      0,79   15 (24)         12 (28)             0.66
  Attempts, *n*                                                 2.9       2.4          0.20   2.4             2.7                 0.27

###### 

Comparison between patients who received IVT therapy and patients who did not in the TICI 2b-3 subgroup

  mTICI 2b-3 subgroup                                           IVT+MT    MT       *p*
  ------------------------------------------------------------- --------- -------- -------
  Patients, *N*                                                 57        15       
  Mean time from puncture to revascularization, min             64        64       0.84
  Mean time from clot visualization to revascularization, min   46        47       0.081
  mTICI 3, *n* (%)                                              12 (21)   7 (47)   0.056
  mRS 0--2, *n* (%)                                             20 (36)   4 (27)   0.76
  Attempts, *n*                                                 2.3       2.3      0.62

###### 

Association of tandem occlusion and cardioembolic etiology with revascularization in the TICI 2b-3 subgroup

  mTICI2b-3                                                     Tandem   Non-tandem   *p*     Cardioembolic   Non-cardioembolic   *p*
  ------------------------------------------------------------- -------- ------------ ------- --------------- ------------------- -------
  *Patients, N*                                                 11       61                   45              27                  
  Mean time from puncture to revascularization, min             76       61           0.075   57              73                  0.09
  Mean time from clot visualization to revascularization, min   62       44           0.053   41              56                  0.024
  mTICI 3, *n* (%)                                              0 (0)    17 (28)      0.27    15 (33)         4 (15)              0.1
  mRS 0--2, *n* (%)                                             5 (45)   19 (32)      0.29    13 (29)         11 (41)             0.32
  Attempts, *n*                                                 3.1      2.1          0.084   2.1             2.5                 0.36
